Previous studies have identified that CSN6 was implicated in tumor progression, because it is overexpressed in multiple common types of cancers, such as cervical cancer, thyroid cancer, colorectal cancer, breast cancer, lung cancer, hepatocellular carcinoma and glioblastoma 15-19. Here, COPS6 is linked to cervical cancer.